These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27712029)

  • 1. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis.
    Agiasotelli D; Alexopoulou A; Vasilieva L; Hadziyannis E; Goukos D; Daikos GL; Dourakis SP
    Liver Int; 2017 Apr; 37(4):576-582. PubMed ID: 27712029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of lipopolysaccharide binding protein in serum and ascites of patients with hepatic cirrhosis complicated with spontaneous bacterial peritonitis].
    Tang NY; Chen WQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jul; 20(7):492-6. PubMed ID: 23044232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.
    Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T
    J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection.
    Bruns T; Reuken PA; Stengel S; Gerber L; Appenrodt B; Schade JH; Lammert F; Zeuzem S; Stallmach A
    Liver Int; 2016 Aug; 36(8):1133-42. PubMed ID: 26901072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections.
    Papp M; Vitalis Z; Altorjay I; Tornai I; Udvardy M; Harsfalvi J; Vida A; Kappelmayer J; Lakatos PL; Antal-Szalmas P
    Liver Int; 2012 Apr; 32(4):603-11. PubMed ID: 22145664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis.
    Dinya T; Tornai T; Vitalis Z; Tornai I; Balogh B; Tornai D; Antal-Szalmas P; Sumegi A; Andrikovics H; Bors A; Tordai A; Papp M
    Liver Int; 2018 Jul; 38(7):1242-1252. PubMed ID: 29235260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality.
    de Oca Arjona MM; Marquez M; Soto MJ; Rodriguez-Ramos C; Terron A; Vergara A; Arizcorreta A; Fernandez-Gutierrez C; Giron-González JA
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):420-7. PubMed ID: 21266909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.
    Gaïni S; Koldkjaer OG; Møller HJ; Pedersen C; Pedersen SS
    Crit Care; 2007; 11(4):R76. PubMed ID: 17625012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.
    Vogt A; Reuken PA; Stengel S; Stallmach A; Bruns T
    World J Gastroenterol; 2016 Mar; 22(11):3275-84. PubMed ID: 27004006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis.
    Thanapirom K; Suksawatamnuay S; Wejnaruemarn S; Thaimai P; Siripon N; Ananchuensook P; Sriphoosanaphan S; Vanichanan J; Treeprasertsuk S; Poovorawan Y; Komolmit P
    Clin Transl Gastroenterol; 2024 May; 15(5):e00697. PubMed ID: 38488171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of markers of bacterial translocation with immune activation in decompensated cirrhosis.
    Mortensen C; Jensen JS; Hobolth L; Dam-Larsen S; Madsen BS; Andersen O; Møller S; Bendtsen F
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1360-6. PubMed ID: 25357217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarifying the role of C-reactive protein as a bacterial infection predictor in decompensated cirrhosis.
    Perdigoto DN; Figueiredo PN; Tomé LF
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):645-651. PubMed ID: 29384797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
    Reiberger T; Ferlitsch A; Payer BA; Mandorfer M; Heinisch BB; Hayden H; Lammert F; Trauner M; Peck-Radosavljevic M; Vogelsang H;
    J Hepatol; 2013 May; 58(5):911-21. PubMed ID: 23262249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1018-24. PubMed ID: 26793843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers.
    Iliaz R; Ozpolat T; Baran B; Demir K; Kaymakoglu S; Besisik F; Akyuz F
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):786-791. PubMed ID: 29521663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis.
    Stengel S; Quickert S; Lutz P; Ibidapo-Obe O; Steube A; Köse-Vogel N; Yarbakht M; Reuken PA; Busch M; Brandt A; Bergheim I; Deshmukh SD; Stallmach A; Bruns T
    Gastroenterology; 2020 May; 158(6):1745-1761. PubMed ID: 31982413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Serum Procalcitonin Level as an Early Marker of Ascitic Fluid Infection in Post Hepatitic Cirrhotic Patients.
    Abu Rahma MZ; Mahran ZG; Shafik EA; Mohareb DA; Abd El-Rady NM; Mustafa MA; Khalil M; Abo-Amer YE; Abd-Elsalam S
    Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):61-67. PubMed ID: 32124702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine: a new diagnostic marker in spontaneous bacterial peritonitis.
    Abdel-Razik A; Eldars W; Elhelaly R; Eldeeb AA; Abdelsalam M; El-Wakeel N; Aboulmagd A
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):779-785. PubMed ID: 29505476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ascitic prostaglandin E2 in diagnosis of spontaneous bacterial peritonitis and prediction of in-hospital mortality in patients with decompensated cirrhosis.
    Luo J; Wu X; Zhang Y; Huang W; Jia B
    Medicine (Baltimore); 2019 Jun; 98(26):e16016. PubMed ID: 31261505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin and macrophage inflammatory protein-1 beta (MIP-1β) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis.
    Lesińska M; Hartleb M; Gutkowski K; Nowakowska-Duława E
    Adv Med Sci; 2014 Mar; 59(1):52-6. PubMed ID: 24797975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.